Company Monitoring Page for Takeda

latest headlines for company on cafepharma

Orexigen takes another body blow from ill-fated Contrave trial
Fierce Pharma
Wed, 03/9/16 - 03:40 pm
Tags:
Orexigen, Contrave, obesity, Takeda, clinical trials
Hoping Vivus and Orexigen can finally kick-start their obesity meds? Don't count on it, analyst says
Fierce Pharma Marketing
Tue, 03/1/16 - 10:56 pm
Tags:
obesity, Vivus, Orexigen, Contrave, Qsymia, Takeda
Takeda-Teva JV 'could be a trendsetter' as Japan pushes for generics: analyst
Fierce Pharma
Mon, 02/8/16 - 09:33 pm
Tags:
Takeda, Teva Pharmaceutical, Japan, generics
Takeda's U.K. unit brings sales force in-house to boost efforts in oncology, IBD
Fierce Pharma Marketing
Thu, 01/21/16 - 09:59 am
Tags:
Takeda, UK
Takeda teams with enGene for gastrointestinal R&D
Fierce Biotech
Wed, 01/13/16 - 10:32 am
Tags:
Takeda, enGene, R&D, gastrointestinal
Takeda Acquires U.S. Biologics Manufacturing Facility
Yahoo
Tue, 01/5/16 - 09:26 pm
Tags:
Takeda, drug manufacturing, Entyvio
Takeda Provides Further Information about Its New Business Venture with Teva
Yahoo
Mon, 12/28/15 - 09:51 am
Tags:
Takeda, Teva Pharmaceutical, generics, Japan
AstraZeneca supercharging its Asia strategy with WuXi and Takeda deals
Fierce Pharma
Wed, 12/16/15 - 03:47 pm
Tags:
AstraZeneca, Asia, WuXi, Takeda, R&D, China
Teva and Takeda Establish Unique Partnership to Meet the Wide-Ranging Needs of Patients and Growing Importance of Generic Medicines Use in Japan
Yahoo
Mon, 11/30/15 - 10:50 am
Tags:
Teva, Takeda, Japan
FDA approves 3rd multiple myeloma med of 2015, Takeda's Ninlaro
BioPharma Dive
Mon, 11/23/15 - 01:19 pm
Tags:
FDA, Takeda, Ninlaro, Multiple Myeloma
Takeda's 'breakthrough' Velcade heir wins early FDA approval in myeloma
Fierce Biotech
Fri, 11/20/15 - 06:20 pm
Tags:
Takeda, Velcade, FDA, ixazomib, Multiple Myeloma
Are Takeda's 900 Contrave reps worth it? Maybe not, analyst says
Fierce Pharma Marketing
Mon, 11/9/15 - 03:38 pm
Tags:
Takeda, Contrave, drug reps, Orexigen
The top 10 biopharma pipeline disasters of 2015
Fierce Biotech
Fri, 10/30/15 - 09:55 am
Tags:
Eli Lilly, GSK, AstraZeneca, Shire, Celladon, Takeda, Merck, Roche, Verastem, evacetrapib, Breo Ellipta, brodalumab, selumetinib, SHP625, Mydicar, Alisertib, suggammadex, sembragiline, Defactinib
Takeda keeps Actos settlement ball rolling with two new resolutions
Fierce Pharma
Mon, 10/12/15 - 11:44 am
Tags:
Takeda, Actos, diabetes
Contrave script growth snags, despite Takeda's 900-strong salesforce
Fierce Pharma Marketing
Tue, 09/29/15 - 09:16 am
Tags:
Contrave, Takeda, Orexigen, obesity
Takeda gets enough takers to complete $2.3B Actos settlement
Fierce Pharma
Mon, 09/14/15 - 05:45 pm
Tags:
Takeda, Actos, diabetes
Here's What Caused Orexigen Therapeutics to Slim Down in August
Motley Fool
Mon, 09/7/15 - 11:44 am
Tags:
Orexigen Therapeutics, Takeda, Contrave
FDA warns of severe joint pain risk with DPP-4 diabetes drugs
Yahoo/Reuters
Fri, 08/28/15 - 05:52 pm
Tags:
FDA, diabetes, joint pain, DPP-4 inhibitor, Merck, Januvia, Onglyza, AstraZeneca, Takeda, Boehringer Ingelheim
Takeda Actos settlement seems shaky as plaintiffs give it the sniff test
Fierce Pharma
Fri, 08/14/15 - 11:17 am
Tags:
Takeda, Actos, diabetes, bladder cancer
Takeda revamps commercial org to synch with R&D
Medical Marketing and Media
Thu, 06/18/15 - 06:11 pm
Tags:
R&D, Takeda

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.